DermTech (DMTK) Misses Q1 EPS by 1c

DermTech (NASDAQ: DMTK) reported Q1 EPS of ($0.58), $0.01 worse than the analyst estimate of ($0.57). Revenue for the quarter came in at $3.85 million versus the consensus estimate of $3.97 million.

For earnings history and earnings-related data on DermTech (DMTK) click here.

You May Also Be Interested In

• Blackhawk Network (HAWK) Reports Q2 Loss of $0.07; Offers Guidance
• Jernigan Capital (JCAP) Tops Q2 EPS by 5c
• Boston Omaha Corporation (BOC) Misses Q2 EPS by 2c